| 2019-12-31 | Zimmer Biomet Holdings, Inc. | $642 | Gift | In-kind items and services | Zimmer Biomet Instruments and Implants Device, General | | 2019 |
| 2019-12-31 | Siemens Medical Solutions USA, Inc. | $592 | Charitable Contribution | In-kind items and services | | | 2019 |
| 2019-12-27 | BioFire Diagnostics, LLC | $1,500 | Research payment | Cash or cash equivalent | BioFire FilmArray 2.0 (FLM2-ASY-0001R) Device, Clinical Diagnostics | Analysis of Semiquantitative Bacterial PCR of sputum as measured by FilmArray Panel compared to conventional culture wit | 2019 |
| 2019-12-20 | Medtronic MiniMed, Inc. | $20,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Minimed 670G System Device, Durable Pump | | 2019 |
| 2019-12-19 | Abbott Laboratories | $6,800 | Research payment | Cash or cash equivalent | Heart Failure Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) | 2019 |
| 2019-12-19 | Novartis Pharmaceuticals Corporation | $2,554 | Research payment | Cash or cash equivalent | ARZERRA Drug, HEMATOLOGY | A PHASE III OPEN LABEL RANDOMIZED MULTICENTER TRIAL OF OFATUMUMAB MAINTENANCE TREATMENT VERSUS NO FURTHER TREATMENT IN S | 2019 |
| 2019-12-19 | Tandem Diabetes Care, Inc. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t-slim insulin pump Device, Endocrinology | | 2019 |
| 2019-12-19 | Tandem Diabetes Care, Inc. | $250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t-slim insulin pump Device, Endocrinology | | 2019 |
| 2019-12-17 | Zimmer Biomet Holdings, Inc. | $2,237 | Education | Cash or cash equivalent | Persona Device, Knees | | 2019 |
| 2019-12-16 | Roche Products Limited | $31,403 | Research payment | Cash or cash equivalent | TECENTRIQ Biological, BioOncology | A PHASE III MULTICENTER RANDOMIZED OPEN LABEL STUDY COMPARING ATEZOLIZUMAB ANTI PD L1 ANTIBODY | 2019 |
| 2019-12-16 | Boston Scientific Corporation | $574 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2019 |
| 2019-12-12 | CSL Behring | $1,948 | Research payment | Cash or cash equivalent | | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 |
| 2019-12-12 | Regeneron Pharmaceuticals, Inc. | $1,928 | Research payment | Cash or cash equivalent | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | Dupilumab as add on therapy for aspirin-exacerbated respiratory disease | 2019 |
| 2019-12-12 | CSL Behring | $50 | Research payment | Cash or cash equivalent | | Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome AEGIS-II | 2019 |
| 2019-12-11 | Merck Sharp & Dohme LLC | $42,137 | Research payment | Cash or cash equivalent | PNEUMOVAX 23 Biological, VACCINE | Serum antibody levels to pneumococcal polysaccharides 22F, 33F, 19A and 6A PCV15 components that correlate with protecti | 2019 |
| 2019-12-09 | Merck Sharp & Dohme LLC | $6 | Research payment | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | PEMBROLIZUMAB IN MUSCLE INVASIVE AND LOCALLY ADVANCED UROTHELIAL CARCINOMA AMBASSADOR | 2019 |
| 2019-12-06 | BioFire Diagnostics, LLC | $368 | Research payment | Cash or cash equivalent | Maine Molecular Pneumonia QC Panel (M340) Device, Clinical Diagnostics | Analysis of Semiquantitative Bacterial PCR of sputum as measured by FilmArray Panel compared to conventional culture wit | 2019 |
| 2019-12-05 | Abbott Laboratories | $725 | Research payment | Cash or cash equivalent | ABSORB Device, Vascular | A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects | 2019 |
| 2019-12-02 | Abbott Laboratories | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Mitra Clip system Device, Vascular | | 2019 |
| 2019-12-02 | Boston Scientific Corporation | $800 | Research payment | Cash or cash equivalent | GENERAL TACHY Device, TACHY | LSS OF 4 SITE | 2019 |
| 2019-11-27 | Edwards Lifesciences Corporation | $40,732 | Research payment | Cash or cash equivalent | | Early-TAVR Trial 2016-07 | 2019 |
| 2019-11-27 | BioFire Diagnostics, LLC | $1,500 | Research payment | Cash or cash equivalent | BioFire FilmArray 2.0 (FLM2-ASY-0001R) Device, Clinical Diagnostics | Analysis of Semiquantitative Bacterial PCR of sputum as measured by FilmArray Panel compared to conventional culture wit | 2019 |
| 2019-11-26 | Merck Sharp & Dohme LLC | $242,598 | Research payment | Cash or cash equivalent | | | 2019 |
| 2019-11-26 | Tandem Diabetes Care, Inc. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t-slim insulin pump Device, Endocrinology | | 2019 |
| 2019-11-26 | Tandem Diabetes Care, Inc. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t-slim insulin pump Device, Endocrinology | | 2019 |
| 2019-11-26 | Tandem Diabetes Care, Inc. | $250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t-slim insulin pump Device, Endocrinology | | 2019 |
| 2019-11-26 | Tandem Diabetes Care, Inc. | $250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t-slim insulin pump Device, Endocrinology | | 2019 |
| 2019-11-22 | Shire North American Group Inc | $27,235 | Research payment | Cash or cash equivalent | CUVITRU Biological, IMMUNOLOGY | THE USE OF 20 SUBCUTANEOUS IMMUNOGLOBULIN REPLACEMENT THERAPY IN PATIENTS WITH B CELL NON HODGKIN'S LYMPHOMA WITH HUMORA | 2019 |
| 2019-11-22 | BioFire Diagnostics, LLC | $1,366 | Research payment | Cash or cash equivalent | BioFire FilmArray Pnuemonia Panel 30 Pouch Kit (RFIT-ASY-0144) Device, Clinical Diagnostics | Analysis of Semiquantitative Bacterial PCR of sputum as measured by FilmArray Panel compared to conventional culture wit | 2019 |
| 2019-11-19 | PFIZER INC. | $97 | Research payment | In-kind items and services | | A PHASE 12 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING FIRSTINHUMAN STUDY TO DESCRIBE THE SAFETY TOLERABILITY | 2019 |
| 2019-11-13 | Abbott Laboratories | $3,468 | Research payment | Cash or cash equivalent | Heart Failure Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) | 2019 |
| 2019-11-07 | McKesson Corporation | $2,500 | Charitable Contribution | Cash or cash equivalent | | | 2019 |
| 2019-11-05 | PFIZER INC. | $145 | Research payment | In-kind items and services | | A PHASE 12 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING FIRSTINHUMAN STUDY TO DESCRIBE THE SAFETY TOLERABILITY | 2019 |
| 2019-11-05 | PFIZER INC. | $52 | Research payment | In-kind items and services | | A PHASE 12 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING FIRSTINHUMAN STUDY TO DESCRIBE THE SAFETY TOLERABILITY | 2019 |
| 2019-11-05 | PFIZER INC. | $5 | Research payment | In-kind items and services | | A PHASE 12 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING FIRSTINHUMAN STUDY TO DESCRIBE THE SAFETY TOLERABILITY | 2019 |
| 2019-11-04 | Boston Scientific Corporation | $9,662 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2019 |
| 2019-11-04 | Boston Scientific Corporation | $344 | Research payment | Cash or cash equivalent | GENERAL TACHY Device, TACHY | LSS OF 4 SITE | 2019 |
| 2019-11-02 | Amarin Pharma, Inc. | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Vascepa Drug, Hypertriglyceridemia | | 2019 |
| 2019-11-02 | Novartis Pharmaceuticals Corporation | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ENTRESTO Drug, CARDIOVASCULAR | | 2019 |
| 2019-10-30 | Celgene Corporation | $600 | Research payment | Cash or cash equivalent | Revlimid Drug, Hematology / Oncology | Connect Myeloid: The Myelofibrosis (MF), Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Regist | 2019 |
| 2019-10-29 | PFIZER INC. | $145 | Research payment | In-kind items and services | | A PHASE 12 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING FIRSTINHUMAN STUDY TO DESCRIBE THE SAFETY TOLERABILITY | 2019 |
| 2019-10-29 | PFIZER INC. | $52 | Research payment | In-kind items and services | | A PHASE 12 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING FIRSTINHUMAN STUDY TO DESCRIBE THE SAFETY TOLERABILITY | 2019 |
| 2019-10-29 | PFIZER INC. | $18 | Research payment | In-kind items and services | | A PHASE 12 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING FIRSTINHUMAN STUDY TO DESCRIBE THE SAFETY TOLERABILITY | 2019 |
| 2019-10-28 | Biosense Webster, Inc. | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Smartablate Device, Generators | | 2019 |
| 2019-10-27 | BioFire Diagnostics, LLC | $1,500 | Research payment | Cash or cash equivalent | BioFire FilmArray 2.0 (FLM2-ASY-0001R) Device, Clinical Diagnostics | Analysis of Semiquantitative Bacterial PCR of sputum as measured by FilmArray Panel compared to conventional culture wit | 2019 |
| 2019-10-24 | CSL Behring | $55,000 | Research payment | Cash or cash equivalent | | A Prospective Case Series Of Subcutaneous Immunoglobulin For Prophylaxis of Infection in Patients with CLL with impaired | 2019 |
| 2019-10-23 | Ortho-Clinical Diagnostics, Inc. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Clinical Chemistry Device, Diagnostics | | 2019 |
| 2019-10-21 | Roche Products Limited | $13,552 | Research payment | Cash or cash equivalent | TECENTRIQ Biological, BioOncology | A PHASE III MULTICENTER RANDOMIZED OPEN LABEL STUDY COMPARING ATEZOLIZUMAB ANTI PD L1 ANTIBODY | 2019 |
| 2019-10-21 | Lilly USA, LLC | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | | | 2019 |
| 2019-10-20 | AstraZeneca Pharmaceuticals LP | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | BRILINTA Drug, Cardiovascular and Metabolism | | 2019 |
| 2019-10-18 | Amgen Inc. | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Corlanor Drug, Cardiology | | 2019 |
| 2019-10-16 | Kyowa Kirin Pharmaceutical Development, Inc | $25,905 | Research payment | Cash or cash equivalent | POTELIGEO Drug, MONOCLONAL ANTIBODY | Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW-0761 mogamulizumab Versus Vorinostat in S | 2019 |
| 2019-10-16 | Tandem Diabetes Care, Inc. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t-slim insulin pump Device, Endocrinology | | 2019 |
| 2019-10-16 | Tandem Diabetes Care, Inc. | $250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t-slim insulin pump Device, Endocrinology | | 2019 |
| 2019-10-09 | Stryker Corporation | $1,905 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | | 2019 |
| 2019-10-09 | Stryker Corporation | $869 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | | 2019 |
| 2019-10-09 | Stryker Corporation | $58 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | | 2019 |
| 2019-10-09 | Stryker Corporation | $46 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | | 2019 |
| 2019-10-07 | Boston Scientific Corporation | $598 | Research payment | Cash or cash equivalent | GENERAL TACHY Device, TACHY | LSS OF 4 SITE | 2019 |
| 2019-10-03 | Chiesi USA, Inc. | $800 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | CLEVIPREX Drug, CARDIOVASCULAR | | 2019 |
| 2019-10-01 | Kyowa Kirin Pharmaceutical Development, Inc | $33,544 | Research payment | Cash or cash equivalent | POTELIGEO Drug, MONOCLONAL ANTIBODY | Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW-0761 mogamulizumab Versus Vorinostat in S | 2019 |
| 2019-09-27 | BioFire Diagnostics, LLC | $1,500 | Research payment | Cash or cash equivalent | BioFire FilmArray 2.0 (FLM2-ASY-0001R) Device, Clinical Diagnostics | Analysis of Semiquantitative Bacterial PCR of sputum as measured by FilmArray Panel compared to conventional culture wit | 2019 |
| 2019-09-25 | Medtronic MiniMed, Inc. | $15,712 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Minimed 670G System Device, Durable Pump | | 2019 |
| 2019-09-23 | SANOFI US SERVICES INC. | $669 | Research payment | Cash or cash equivalent | DUPIXENT Drug, IMMUNOLOGY | One Year Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Pediatric Patients With Asthma Who Part | 2019 |
| 2019-09-17 | Kyowa Kirin Pharmaceutical Development, Inc | $43,705 | Research payment | Cash or cash equivalent | POTELIGEO Drug, MONOCLONAL ANTIBODY | Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW-0761 mogamulizumab Versus Vorinostat in S | 2019 |
| 2019-09-17 | Kyowa Kirin Pharmaceutical Development, Inc | $41,353 | Research payment | Cash or cash equivalent | POTELIGEO Drug, MONOCLONAL ANTIBODY | Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW-0761 mogamulizumab Versus Vorinostat in S | 2019 |
| 2019-09-17 | Kyowa Kirin Pharmaceutical Development, Inc | $23,281 | Research payment | Cash or cash equivalent | POTELIGEO Drug, MONOCLONAL ANTIBODY | Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW-0761 mogamulizumab Versus Vorinostat in S | 2019 |
| 2019-09-17 | Kyowa Kirin Pharmaceutical Development, Inc | $10,877 | Research payment | Cash or cash equivalent | POTELIGEO Drug, MONOCLONAL ANTIBODY | Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW-0761 mogamulizumab Versus Vorinostat in S | 2019 |
| 2019-09-17 | Kyowa Kirin Pharmaceutical Development, Inc | $2,585 | Research payment | Cash or cash equivalent | POTELIGEO Drug, MONOCLONAL ANTIBODY | Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW-0761 mogamulizumab Versus Vorinostat in S | 2019 |
| 2019-09-16 | Boston Scientific Corporation | $3,351 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2019 |
| 2019-09-13 | Edwards Lifesciences Corporation | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Edwards SAPIEN 3 Transcatheter Heart Valve Device, Transcatheter Heart Valves | | 2019 |
| 2019-09-11 | Tandem Diabetes Care, Inc. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t-slim insulin pump Device, Endocrinology | | 2019 |
| 2019-09-09 | SANOFI US SERVICES INC. | $669 | Research payment | Cash or cash equivalent | DUPIXENT Drug, IMMUNOLOGY | One Year Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Pediatric Patients With Asthma Who Part | 2019 |
| 2019-09-05 | Abbott Laboratories | $2,275 | Research payment | Cash or cash equivalent | ABSORB Device, Vascular | A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects | 2019 |
| 2019-08-27 | BioFire Diagnostics, LLC | $1,500 | Research payment | Cash or cash equivalent | BioFire FilmArray 2.0 (FLM2-ASY-0001R) Device, Clinical Diagnostics | Analysis of Semiquantitative Bacterial PCR of sputum as measured by FilmArray Panel compared to conventional culture wit | 2019 |
| 2019-08-23 | Incyte Corporation | $11 | Research payment | Cash or cash equivalent | | PROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED | 2019 |
| 2019-08-16 | E.R. Squibb & Sons, L.L.C. | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | | 2019 |
| 2019-08-07 | Boston Scientific Corporation | $2,000 | Grant | Cash or cash equivalent | GENERAL - STRUCTURAL HEART Device, STRUCTURAL HEART | | 2019 |
| 2019-08-07 | BioFire Diagnostics, LLC | $368 | Research payment | Cash or cash equivalent | Maine Molecular Pneumonia QC Panel (M340) Device, Clinical Diagnostics | Analysis of Semiquantitative Bacterial PCR of sputum as measured by FilmArray Panel compared to conventional culture wit | 2019 |
| 2019-08-06 | BioFire Diagnostics, LLC | $2,673 | Research payment | Cash or cash equivalent | BioFire FilmArray Pneumonia Kit (RFIT-ASY-0144) Device, Clinical Diagnostics | Analysis of Semiquantitative Bacterial PCR of sputum as measured by FilmArray Panel compared to conventional culture wit | 2019 |
| 2019-08-05 | Boston Scientific Corporation | $10,992 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2019 |
| 2019-08-01 | Janssen Pharmaceuticals, Inc | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | XARELTO Drug, Cardiovascular & Metabolism | | 2019 |
| 2019-08-01 | Amgen Inc. | $4 | Research payment | In-kind items and services | XGEVA Biological, Oncology | P3 Multiple Myeloma Frontline | 2019 |
| 2019-07-31 | Ortho-Clinical Diagnostics, Inc. | $6,120 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Clinical Chemistry Device, Diagnostics | | 2019 |
| 2019-07-29 | SANOFI US SERVICES INC. | $1,338 | Research payment | Cash or cash equivalent | DUPIXENT Drug, IMMUNOLOGY | One Year Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Pediatric Patients With Asthma Who Part | 2019 |
| 2019-07-27 | BioFire Diagnostics, LLC | $1,500 | Research payment | Cash or cash equivalent | BioFire FilmArray 2.0 (FLM2-ASY-0001R) Device, Clinical Diagnostics | Analysis of Semiquantitative Bacterial PCR of sputum as measured by FilmArray Panel compared to conventional culture wit | 2019 |
| 2019-07-22 | Roche Products Limited | $7,806 | Research payment | Cash or cash equivalent | TECENTRIQ Biological, BioOncology | A PHASE III MULTICENTER RANDOMIZED OPEN LABEL STUDY COMPARING ATEZOLIZUMAB ANTI PD L1 ANTIBODY | 2019 |
| 2019-07-16 | CSL Behring | $2,100 | Research payment | Cash or cash equivalent | Hizentra Biological, Immunology | Safety and Tolerability of Higher Infusion Parameters of IgPro20 Hizentra in Subjects With Primary Immunodeficiency PID | 2019 |
| 2019-07-16 | Stryker Corporation | $1,891 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | | 2019 |
| 2019-07-16 | Stryker Corporation | $959 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | | 2019 |
| 2019-07-16 | Stryker Corporation | $54 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | | 2019 |
| 2019-07-16 | Stryker Corporation | $43 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | | 2019 |
| 2019-07-02 | SANOFI US SERVICES INC. | $876 | Research payment | Cash or cash equivalent | DUPIXENT Drug, IMMUNOLOGY | One Year Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Pediatric Patients With Asthma Who Part | 2019 |
| 2019-06-30 | Abbott Laboratories | $70 | Research payment | In-kind items and services | Heart Failure Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) | 2019 |
| 2019-06-27 | Medtronic MiniMed, Inc. | $21,331 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Minimed 670G System Device, Durable Pump | | 2019 |
| 2019-06-27 | McKesson Corporation | $2,500 | Charitable Contribution | Cash or cash equivalent | | | 2019 |
| 2019-06-27 | BioFire Diagnostics, LLC | $1,500 | Research payment | Cash or cash equivalent | BioFire FilmArray 2.0 (FLM2-ASY-0001R) Device, Clinical Diagnostics | Analysis of Semiquantitative Bacterial PCR of sputum as measured by FilmArray Panel compared to conventional culture wit | 2019 |
| 2019-06-26 | Tandem Diabetes Care, Inc. | $250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t-slim insulin pump Device, Endocrinology | | 2019 |
| 2019-06-21 | Abbott Laboratories | $790 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | | | 2019 |
| 2019-06-14 | Boston Scientific Corporation | $344 | Research payment | Cash or cash equivalent | GENERAL TACHY Device, TACHY | LSS OF 4 SITE | 2019 |
| 2019-06-11 | Abbott Laboratories | $4,475 | Research payment | Cash or cash equivalent | ABSORB Device, Vascular | A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects | 2019 |
| 2019-06-10 | SANOFI US SERVICES INC. | $2,737 | Research payment | Cash or cash equivalent | DUPIXENT Drug, IMMUNOLOGY | One Year Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Pediatric Patients With Asthma Who Part | 2019 |
| 2019-06-03 | Boston Scientific Corporation | $24,446 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2019 |
| 2019-06-03 | Boston Scientific Corporation | $4,611 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2019 |
| 2019-05-29 | SANOFI US SERVICES INC. | $3,000 | Research payment | Cash or cash equivalent | DUPIXENT Drug, IMMUNOLOGY | One Year Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Pediatric Patients With Asthma Who Part | 2019 |
| 2019-05-28 | Kyowa Kirin Pharmaceutical Development, Inc | $8,729 | Research payment | Cash or cash equivalent | POTELIGEO Drug, MONOCLONAL ANTIBODY | Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW-0761 mogamulizumab Versus Vorinostat in S | 2019 |
| 2019-05-27 | BioFire Diagnostics, LLC | $1,500 | Research payment | Cash or cash equivalent | BioFire FilmArray 2.0 (FLM2-ASY-0001R) Device, Clinical Diagnostics | Analysis of Semiquantitative Bacterial PCR of sputum as measured by FilmArray Panel compared to conventional culture wit | 2019 |
| 2019-05-23 | Incyte Corporation | $3,746 | Research payment | Cash or cash equivalent | | PROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED | 2019 |
| 2019-05-23 | Philips North America LLC | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ELCA Device, Devices | | 2019 |
| 2019-05-20 | SANOFI US SERVICES INC. | $2,800 | Research payment | Cash or cash equivalent | DUPIXENT Drug, IMMUNOLOGY | A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in | 2019 |
| 2019-05-20 | ZOLL Medical Corporation | $250 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Device, DEFIBRILLATOR | | 2019 |
| 2019-05-16 | CSL Behring | $55,000 | Research payment | Cash or cash equivalent | | A Prospective Case Series Of Subcutaneous Immunoglobulin For Prophylaxis of Infection in Patients with CLL with impaired | 2019 |
| 2019-05-10 | Edwards Lifesciences Corporation | $41,783 | Research payment | Cash or cash equivalent | | Early-TAVR Trial 2016-07 | 2019 |
| 2019-05-08 | Ortho-Clinical Diagnostics, Inc. | $6,525 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Clinical Chemistry Device, Diagnostics | | 2019 |
| 2019-05-06 | Roche Products Limited | $15,390 | Research payment | Cash or cash equivalent | TECENTRIQ Biological, BioOncology | A PHASE III MULTICENTER RANDOMIZED OPEN LABEL STUDY COMPARING ATEZOLIZUMAB ANTI PD L1 ANTIBODY | 2019 |
| 2019-05-06 | Boston Scientific Corporation | $3,081 | Research payment | Cash or cash equivalent | GENERAL TACHY Device, TACHY | LSS OF 4 SITE | 2019 |
| 2019-05-03 | Amgen Inc. | $3,257 | Research payment | Cash or cash equivalent | XGEVA Biological, Oncology | P3 Multiple Myeloma Frontline | 2019 |
| 2019-05-03 | Novartis Pharmaceuticals Corporation | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ENTRESTO Drug, CARDIOVASCULAR | | 2019 |
| 2019-05-03 | APPLIED MEDICAL TECHNOLOGY INC | $250 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Bridle Device, Enteral | | 2019 |
| 2019-05-01 | PFIZER INC. | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | | 2019 |
| 2019-05-01 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $500 | Grant | Cash or cash equivalent | LifeVest Device, Electromedical and Electrotherapeutic Apparatus | | 2019 |
| 2019-04-29 | Incyte Corporation | $12 | Research payment | Cash or cash equivalent | | PROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED | 2019 |
| 2019-04-27 | BioFire Diagnostics, LLC | $1,500 | Research payment | Cash or cash equivalent | BioFire FilmArray 2.0 (FLM2-ASY-0001R) Device, Clinical Diagnostics | Analysis of Semiquantitative Bacterial PCR of sputum as measured by FilmArray Panel compared to conventional culture wit | 2019 |
| 2019-04-25 | CSL Behring | $1,500 | Research payment | Cash or cash equivalent | Hizentra Biological, Immunology | Safety and Tolerability of Higher Infusion Parameters of IgPro20 Hizentra in Subjects With Primary Immunodeficiency PID | 2019 |
| 2019-04-25 | CSL Behring | $1,200 | Research payment | Cash or cash equivalent | Hizentra Biological, Immunology | Safety and Tolerability of Higher Infusion Parameters of IgPro20 Hizentra in Subjects With Primary Immunodeficiency PID | 2019 |
| 2019-04-25 | CSL Behring | $750 | Research payment | Cash or cash equivalent | Hizentra Biological, Immunology | Safety and Tolerability of Higher Infusion Parameters of IgPro20 Hizentra in Subjects With Primary Immunodeficiency PID | 2019 |
| 2019-04-23 | Zimmer Biomet Holdings, Inc. | $978 | Education | Cash or cash equivalent | Comprehensive Shoulder Device, Extremities | | 2019 |
| 2019-04-22 | SANOFI US SERVICES INC. | $242 | Research payment | Cash or cash equivalent | DUPIXENT Drug, IMMUNOLOGY | A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in | 2019 |
| 2019-04-19 | PFIZER INC. | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | ELIQUIS Drug, CARDIOVASCULAR;METABOLIC DISEASE | | 2019 |
| 2019-04-18 | CSL Behring | $428 | Research payment | Cash or cash equivalent | Hizentra Biological, Immunology | Safety and Tolerability of Higher Infusion Parameters of IgPro20 Hizentra in Subjects With Primary Immunodeficiency PID | 2019 |
| 2019-04-12 | Stryker Corporation | $1,674 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | | 2019 |
| 2019-04-12 | Stryker Corporation | $797 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | | 2019 |
| 2019-04-12 | Stryker Corporation | $51 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | | 2019 |
| 2019-04-12 | Stryker Corporation | $31 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | | 2019 |
| 2019-04-10 | Boston Scientific Corporation | $500 | Grant | Cash or cash equivalent | GENERAL - STRUCTURAL HEART Device, STRUCTURAL HEART | | 2019 |
| 2019-04-09 | AstraZeneca Pharmaceuticals LP | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | BRILINTA Drug, Cardiovascular and Metabolism | | 2019 |
| 2019-04-09 | Smith+Nephew, Inc. | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | | | 2019 |
| 2019-04-08 | BioFire Diagnostics, LLC | $527 | Research payment | Cash or cash equivalent | BioFire FilmArray Pneumonia Kit (RFIT-ASY-0144) Device, Clinical Diagnostics | Analysis of Semiquantitative Bacterial PCR of sputum as measured by FilmArray Panel compared to conventional culture wit | 2019 |
| 2019-04-03 | Abbott Laboratories | $500 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Cardiovascular- Research only Device, Cardiac Arrhythmias and Heart Failure | | 2019 |
| 2019-04-02 | Shire North American Group Inc | $205,389 | Research payment | In-kind items and services | CUVITRU Biological, IMMUNOLOGY | THE USE OF 20 SUBCUTANEOUS IMMUNOGLOBULIN REPLACEMENT THERAPY IN PATIENTS WITH B CELL NON HODGKIN'S LYMPHOMA WITH HUMORA | 2019 |
| 2019-04-01 | SANOFI US SERVICES INC. | $7,484 | Research payment | Cash or cash equivalent | DUPIXENT Drug, IMMUNOLOGY | A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in | 2019 |
| 2019-03-31 | Abbott Laboratories | $23 | Research payment | In-kind items and services | Heart Failure Device, Cardiac Arrhythmias and Heart Failure | Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) | 2019 |
| 2019-03-27 | Olympus America Inc. | $21,650 | Gift | In-kind items and services | Device, Surgical Endoscopy Products | | 2019 |
| 2019-03-27 | Medtronic MiniMed, Inc. | $17,587 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Minimed 630G Device, Durable Pump | | 2019 |
| 2019-03-27 | BioFire Diagnostics, LLC | $1,500 | Research payment | Cash or cash equivalent | BioFire FilmArray 2.0 (FLM2-ASY-0001R) Device, Clinical Diagnostics | Analysis of Semiquantitative Bacterial PCR of sputum as measured by FilmArray Panel compared to conventional culture wit | 2019 |
| 2019-03-27 | Amgen Inc. | $930 | Research payment | Cash or cash equivalent | | GALACTIC-HF | 2019 |
| 2019-03-26 | Abbott Laboratories | $200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | | | 2019 |
| 2019-03-22 | Merck Sharp & Dohme LLC | $86,298 | Research payment | Cash or cash equivalent | PNEUMOVAX 23 Biological, VACCINE | Protective levels of anti-pneumococcal polysaccharide 22F and 33F antibodies induced by PCV15 in murine models of invasi | 2019 |
| 2019-03-19 | Abbott Laboratories | $395 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | | | 2019 |
| 2019-03-18 | Boston Scientific Corporation | $674 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2019 |
| 2019-03-13 | Abbott Laboratories | $7,300 | Research payment | Cash or cash equivalent | Absorb Device, Vascular | A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects | 2019 |
| 2019-03-13 | Janssen Pharmaceuticals, Inc | $2,000 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | XARELTO Drug, Cardiovascular & Metabolism | | 2019 |
| 2019-03-05 | Smith+Nephew, Inc. | $1,374 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Biosure Device, Sports Med Knee | | 2019 |
| 2019-02-28 | BioFire Diagnostics, LLC | $368 | Research payment | Cash or cash equivalent | Maine Molecular Pneumonia QC Kit (M340) Device, Clinical Diagnostics | Analysis of Semiquantitative Bacterial PCR of sputum as measured by FilmArray Panel compared to conventional culture wit | 2019 |
| 2019-02-27 | BioFire Diagnostics, LLC | $5,650 | Research payment | Cash or cash equivalent | BioFire FilmArray 2.0 Refurb (FLM2-ASY-001R) Device, Clinical Diagnostics | Analysis of Semiquantitative Bacterial PCR of sputum as measured by FilmArray Panel compared to conventional culture wit | 2019 |
| 2019-02-27 | BioFire Diagnostics, LLC | $1,500 | Research payment | Cash or cash equivalent | BioFire FilmArray 2.0 (FLM2-ASY-0001R) Device, Clinical Diagnostics | Analysis of Semiquantitative Bacterial PCR of sputum as measured by FilmArray Panel compared to conventional culture wit | 2019 |
| 2019-02-25 | Roche Products Limited | $23,618 | Research payment | Cash or cash equivalent | TECENTRIQ Biological, BioOncology | A PHASE III MULTICENTER RANDOMIZED OPEN LABEL STUDY COMPARING ATEZOLIZUMAB ANTI PD L1 ANTIBODY | 2019 |
| 2019-02-19 | Boston Scientific Corporation | $10,523 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2019 |
| 2019-02-12 | Smith+Nephew, Inc. | $1,360 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Biosure Device, Sports Med Knee | | 2019 |
| 2019-02-07 | Regeneron Pharmaceuticals, Inc. | $156,081 | Research payment | Cash or cash equivalent | DUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY | Dupilumab as add on therapy for aspirin-exacerbated respiratory disease | 2019 |
| 2019-02-05 | Incyte Corporation | $1,395 | Research payment | Cash or cash equivalent | | PROSPECTIVE, NON INTERVENTIONAL STUDY OF DISEASE PROGRESSION AND TREATMENT OF PATIENTS WITH POLYCYTHEMIA VERA IN UNITED | 2019 |
| 2019-02-04 | SANOFI US SERVICES INC. | $2,026 | Research payment | Cash or cash equivalent | DUPIXENT Drug, IMMUNOLOGY | A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in | 2019 |
| 2019-02-01 | Shire North American Group Inc | $136,926 | Research payment | In-kind items and services | CUVITRU Biological, IMMUNOLOGY | THE USE OF 20 SUBCUTANEOUS IMMUNOGLOBULIN REPLACEMENT THERAPY IN PATIENTS WITH B CELL NON HODGKIN'S LYMPHOMA WITH HUMORA | 2019 |
| 2019-02-01 | Amgen Inc. | $11 | Research payment | In-kind items and services | XGEVA Biological, Oncology | P3 Multiple Myeloma Frontline | 2019 |
| 2019-01-29 | Amgen Inc. | $12,697 | Research payment | Cash or cash equivalent | | GALACTIC-HF | 2019 |
| 2019-01-23 | Ortho-Clinical Diagnostics, Inc. | $6,411 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Clinical Chemistry Device, Diagnostics | | 2019 |
| 2019-01-23 | Tandem Diabetes Care, Inc. | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t-slim insulin pump Device, Endocrinology | | 2019 |
| 2019-01-22 | Kyowa Kirin Pharmaceutical Development, Inc | $1,900 | Research payment | Cash or cash equivalent | POTELIGEO Drug, MONOCLONAL ANTIBODY | Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW-0761 mogamulizumab Versus Vorinostat in S | 2019 |
| 2019-01-22 | Boston Scientific Corporation | $337 | Research payment | Cash or cash equivalent | CLINICAL TRIAL PRODUCT Device, CLINICAL TRIAL PRODUCT | ASAP TOO | 2019 |
| 2019-01-17 | Amgen Inc. | $3,297 | Research payment | In-kind items and services | | GALACTIC-HF | 2019 |
| 2019-01-15 | Bard Peripheral Vascular, Inc. | $21,025 | Research payment | Cash or cash equivalent | LUTONIX Device, PERIPHERAL VASCULAR | LUTONIX AV PAS CL003301 | 2019 |
| 2019-01-10 | Merck Sharp & Dohme LLC | $31,602 | Research payment | Cash or cash equivalent | PNEUMOVAX 23 Biological, VACCINE | Serum antibody levels to pneumococcal polysaccharides 22F, 33F, 19A and 6A PCV15 components that correlate with protecti | 2019 |
| 2019-01-08 | Stryker Corporation | $1,739 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | | 2019 |
| 2019-01-08 | Stryker Corporation | $957 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | | 2019 |
| 2019-01-08 | Stryker Corporation | $70 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | | 2019 |
| 2019-01-08 | Stryker Corporation | $17 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REPROCESSED DEVICE Device, HYGIA HEALTH SERVICES | | 2019 |
| 2019-01-03 | Tandem Diabetes Care, Inc. | $250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | t-slim insulin pump Device, Endocrinology | | 2019 |
| 2019-01-01 | Amgen Inc. | $512 | Research payment | In-kind items and services | | GALACTIC-HF | 2019 |
Comments